Plancorp, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Plancorp, LLC

$2.44 Billion
Q3 2024

A detailed history of Plancorp, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Plancorp, LLC holds 921 shares of REGN stock, worth $646,403. This represents 0.04% of its overall portfolio holdings.

Number of Shares

921

Previous 918 0.33%

Holding current value

$646,403

Previous $964,000 0.41%

% of portfolio

0.04%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $3,072 - $3,605	3 Added 0.33%	921 $968,000
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $7,065 - $8,569	8 Added 0.88%	918 $964,000
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $10,832 - $11,920	12 Added 1.34%	910 $875,000
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $15,503 - $17,634	20 Added 2.28%	898 $788,000
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $7,616 - $9,288	11 Added 1.27%	878 $722,000
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $700 - $830	-1 Reduced 0.12%	867 $622,000
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $23,136 - $28,116	-34 Reduced 3.77%	868 $713,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $2,117 - $2,299	3 Added 0.33%	902 $650,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $13,201 - $16,659	23 Added 2.63%	899 $619,000
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $767,690 - $1.03 Million	-1,400 Reduced 61.51%	876 $518,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $10,117 - $11,873	17 Added 0.75%	2,276 $1.59 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $21,195 - $26,167	39 Added 1.76%	2,259 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1,722 - $2,042	3 Added 0.14%	2,220 $1.34 Million
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $144,924 - $184,217	-303 Reduced 12.02%	2,217 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $1.37 Million - $1.66 Million	2,520 New	2,520 $1.41 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Account